AI RadarWe read first, then explain what changed
中

← Back to editorial briefs

AI medicine fact-check

Did AI cure cancer? Moderna surged 177%, but the real breakthrough is more important than the headline

Last updated 2026-08-20Editorial synthesis: signals connected before judgementNot a wire dump; facts, judgement, and unknowns are separated
Original workflow diagram showing tumor sequencing, AI selection of up to 34 neoantigens, individualized mRNA production, and combination with Keytruda
Editorial diagram: AI supports neoantigen selection and individualized manufacturing; a positive Phase 3 result is not approval and does not mean AI has cured cancer.
Bottom line

Moderna and Merck's individualized mRNA neoantigen therapy plus Keytruda is the first of its kind to meet recurrence-free and distant-metastasis-free endpoints in Phase 3. AI supports neoantigen selection and manufacturing, but this is not proof that AI has cured cancer.

Moderna and Merck's individualized mRNA neoantigen therapy plus Keytruda is the first of its kind to meet recurrence-free and distant-metastasis-free endpoints in Phase 3. AI supports neoantigen selection and manufacturing, but this is not proof that AI has cured cancer.

This essay is currently written in Chinese.